Uncovering the molecular mechanisms of Fructus Choerospondiatis against coronary heart disease using network pharmacology analysis and experimental pharmacology

作用机理 药理学 系统药理学 过氧化物酶体增殖物激活受体γ AKT1型 机制(生物学) 计算生物学 安普克 过氧化物酶体增殖物激活受体 冠心病 受体 化学 信号转导 医学 体外 生物 生物化学 激酶 内科学 药品 PI3K/AKT/mTOR通路 蛋白激酶A 哲学 认识论
作者
Xun Gao,Yue Zhang,Tingting Li,J Li,Yingying Su,Hongsen Wang,Zhankuan Yan,Kunming Qin
出处
期刊:Analytical Biochemistry [Elsevier BV]
卷期号:675: 115214-115214 被引量:4
标识
DOI:10.1016/j.ab.2023.115214
摘要

Fructus Choerospondiatis (FC), a Mongolian medicine, was mainly used in Mongolian medical theory for the treatment of coronary heart disease (CHD). Nonetheless, the main components and mechanisms of action of FC in the treatment of coronary artery disease have not been studied clearly. Aim of the study: The aim of this study is to identify the components of FC and analyze the pathways affected by the targets of these components to probe into the potential mechanisms of action of FC on coronary heart disease. Materials and methods: Identification of compounds in FC employing high performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (HPLC-QTOF-MS) method, then further investigate the network pharmacology and molecular docking to obtain potential targets and elucidate the potential mechanism of action of FC in the therapy of CHD. Experimental validation was established to verify the mechanism of FC in vitro. Results: 21 FC components were identified and 65 overlapping targets were gained. In addition, these ingredients regulated AMPK and PPAR signaling pathway by 65 target genes including IL6, AKT1 and PPARg, etc. Molecular docking displayed that the binding ability of the key target PPARg to FC components turned out to be better. Experimental validation proved that FC treatment decreased the expression of PPARg (p < 0.05) compare with model group, which may be involved in the PPAR signaling pathway. Conclusions: This study was the first to elucidate the mechanism of action of components of FC for the treatment of CHD using network pharmacology. It alleviated CHD by inhibiting the expression of PPARg to attenuate hypoxia/reoxygenation injury, and the results give a basis for elucidating the molecular mechanism of action of FC for the treatment of coronary heart disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.2的应助被皇后采纳,获得10
刚刚
斯文败类的应助被天天采纳,获得10
刚刚
刚刚
科研通AI2S的应助被Jessica采纳,获得10
1秒前
2秒前
歪歪完成签到 ,获得积分10
2秒前
2秒前
wswalnut关注了科研通微信公众号
3秒前
张小白的应助被gxhjky采纳,获得10
3秒前
董文强发布了新的文献求助10
3秒前
什么呀发布了新的文献求助10
4秒前
雾峰完成签到,获得积分10
4秒前
4秒前
慕青的应助被pump采纳,获得10
4秒前
5秒前
Mia123的应助被无知的h采纳,获得200
5秒前
linzhy完成签到,获得积分10
6秒前
随风完成签到,获得积分10
6秒前
li完成签到,获得积分10
6秒前
苏浩然发布了新的文献求助10
7秒前
7秒前
8秒前
9秒前
学术文献互助的应助被各方面采纳,获得200
9秒前
9秒前
ww发布了新的文献求助10
9秒前
10秒前
无极微光的应助被迷路的帽子采纳,获得20
10秒前
10秒前
脑洞疼的应助被ghg采纳,获得10
11秒前
11秒前
bkagyin的应助被xixi采纳,获得10
11秒前
lonk77完成签到,获得积分10
11秒前
12秒前
啊pang发布了新的文献求助10
12秒前
小白龙完成签到 ,获得积分10
12秒前
Akim的应助被qiujiliang采纳,获得10
13秒前
13秒前
13秒前
CodeCraft的应助被Canon大炮采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8156499
求助须知:如何正确求助?哪些是违规求助? 9552615
关于积分的说明 21710463
捐赠科研通 7745506
什么是DOI,文献DOI怎么找? 3426576
关于科研通互助平台的介绍 2551389
邀请新用户注册赠送积分活动 2470382